I discuss Bidstack #BIDS , Team17 #TM17 Feedback #FDBK and IMC Exploration #IMC #IMCP with Justin Waite on the VoxPodcast podcast

RNS Number: 9022 I Feedback PLC 13 August 2019 Feedback plc. Cambridge, 13 August 2019: Further to its announcement on 12 August 2019, Feedback plc, the specialist medical imaging technology company, announces that it will hold a general meeting of the Company at 1.00 p.m. on 29 August 2019, at the offices of Peterhouse Capital Limited at 80 Cheapside, London EC2V 6...

Proposed placing and subscription to raise £2 million, proposed grant of options, proposed amendment to Share Option Scheme and notice of General Meeting. Cambridge, 12 August 2019: Feedback plc, the specialist medical imaging technology company, announces that it has conditionally raised a total of £2 million via a proposed placing by Peterhouse Capital...

Alan Green talks ECR Minerals #ECR, Smart Metering #SMS, Sativa Group #SATI, Feedback #FDBK & Petrel Resources #PET with Justin Waite on the Vox Markets podcast. Interview starts 49 minutes and 10 seconds in.

RNS Number: 2506 I Feedback PLC 07 August 2019 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations No. 596/ 2014. Cambridge, 7 August 2019: Feedback plc, the specialist medical imaging technology company, notes the recent online commentary regarding a...

I discuss Thomas Cook #TCG Volga Gas #VGAS Feedback #FDBK Open Orphan #ORPH and European Metals Holdings #EMH with Justin on the Vox Markets podcast

RNS Number: 8929 G Feedback PLC 26 July 2019. Cambridge, 26 July 2019: Further to the Company's strategic review announcement on 10 July 2019, Feedback plc, the specialist medical imaging technology company, today provides an update on its new clinical messaging product: Bleepa TM. Bleepa TM, its new app for clinicians, is currently in beta development and will be...

Feedback Plc (FDBK.L) Announced the outcome of its strategic review following the appointment of Dr Tom Oakley as CEO in April 2019. The Board stated that by incorporating a dedicated, encrypted messaging function to its existing Cadran technology, it can become the only medical communication device on the market capable of sharing clinical grade medical imaging directly from a hospital Picture Archiving and Communications System (PACS) to mobile devices, ensuring the safe handling of patient data and facilitating a secure means of communication for clinicians across the UK. The Directors believe this new product will also be the only communication tool to be a CE marked medical device. Separately, the company announced, in its trading update for the year ended 31 May 2019, that it expects an unaudited revenue of £0.56 million for the period, an increase of 23% on the previous financial year (£0.46 million), following new hires and investment in product sales as indicated at the trading update in April 2019.

RNS Number: 0522 F Feedback PLC 10 July 2019 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations No. 596/ 2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public...

RNS Number: 6572 B Feedback PLC 10 June 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

RNS Number: 5246 B Feedback PLC 07 June 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Feedback Plc (FDBK.L) Announced, in its trading update for the financial year ending 31 May 2019, that the investment in new hires for Cadran, along with the agreement with Future Processing, signed in January 2019, to accelerate Feedback Medical's technology development and innovation, has increased the company's cost base, the principal benefit of which will not be realised until the next financial year. As a result, the loss for the current financial year will reflect such investment but not the total anticipated income. Additionally, the company has appointed of Dr Tom Oakley as the new CEO of the company, a strategic review of the business is currently underway. A further announcement will be made in due course.

RNS Number: 0173 X Feedback PLC 25 April 2019 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations No. 596/ 2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public...

RNS Number: 0173 X Feedback PLC 25 April 2019 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations No. 596/ 2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public...

I discuss Feedback #FDBK European Metals Holdings #EMH Destiny Pharma #DEST & Bidstack #BIDS with Justin Waite on the Vox Markets podcast. The interview is 11 minutes 36 seconds in.